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CLINICAL UPDATES 
Optimising fitness for major vascular surgery 
Ruth Benson clinical lecturer in vascular surgery 1, Gordon McGregor clinical exercise physiologist 2, 
Mishkat Shehata academic clinical fellow and general practice registrar3, Christopher Imray professor 
of vascular surgery 4 
1Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; 2Centre for Sport, Exercise & Life Sciences, Coventry 
University, Coventry, UK; 3Unit of Academic Primary Care, University of Warwick, Coventry, UK; 4Warwick Medical School, Coventry University and 
Exeter University, UK 
What you need to know 
Interventions such as increasing physical activity, optimising management
of comorbidities, and smoking cessation can all improve outcomes after 
surgery 
There is no guidance on when to introduce exercise interventions before
surgery. Earlier is better (eg, at the time of referral) 
Vascular conditions, including aortic aneurysm, are not a contraindication
to low intensity aerobic exercise 
Major vascular surgeries, such as aortic aneurysm repair, carotid
endarterectomy, and lower limb revascularisation, are
increasingly common and carry a high risk. More than 200
million people are affected by peripheral arterial disease
worldwide,1 of whom 10-20% require surgery. In the UK,
1.2-1.5% of men over 65 have an abdominal aortic aneurysm,
and more than 4000 repairs were performed in 2017.2 3 Between
7% and 18% of ischaemic strokes are attributed to carotid artery
stenosis. About 4000 patients undergo carotid endarterectomy
in the UK each year.4 5 
In this article, we review key preoperative interventions that
can be started in primary care at the time of referral to a vascular
surgeon. The decision whether a patient is fit for surgery will
likely be made by the specialist vascular team following
evaluation and imaging. However, early interventions initiated
in primary care can potentially improve patient outcomes, even
when there is uncertainty around a patient’s suitability for 
surgery. 
 
Search strategy 
We searched Medline and the Cochrane database for trials and clinical 
guidelines relating to abdominal aortic aneurysm surgery, lower limb bypass,
and carotid endarterectomy. We considered guidelines from the National
Institute for Health and Care Excellence (NICE), the European Society of
Vascular Surgery, the European Society of Cardiology, and the Society of
Vascular Surgery for key recommendations related to current vascular practice.
Where possible, we relied on studies on major vascular surgeries, such as
carotid endarterectomy, aneurysm repair, or peripheral limb revascularisation.
If evidence was lacking, sources relating to other surgical specialties were
used, and this has been stated in the text. 
Why is it important? 
Patients undergoing major vascular surgery frequently have
comorbidities, such as older age, hypertension, existing cardiac
disease, and a history of smoking. Optimising their fitness for
surgery is challenging but can help the patient undergo surgery
and improve outcomes. Cardiovascular risk factors are the most
common comorbidities linked to long term mortality. Ischaemic
heart disease is an important cause of death in patients who have
had surgery for abdominal aortic aneurysm, and was responsible
for more than 25% of deaths, compared with ≤6% for early
surgical or aneurysm specific complications, in two large trials
in the UK.6 The European Society for Vascular Surgery recently
reported that up to 70% of patients with peripheral arterial
disease or abdominal aortic aneurysm had multi site vascular
disease.7 This was based on several cohort studies where either 
ultrasound or coronary angiography were used to detect carotid
and cardiac disease in patients undergoing surgery for peripheral
arterial disease. In a Swedish registry study with 66 189 patients
diagnosed with peripheral arterial disease, nearly 30% of total
healthcare costs were for management of cardiovascular disease,
as hospitalisation or outpatient visits.8 
Poor fitness is associated with a greater risk of perioperative
mortality or major complications after surgery for abdominal
aortic aneurysm for both endovascular and open repair in several 
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prospective observational studies.9-13 No data are available for 
lower limb or carotid surgery. 
How is the patient’s physical fitness for
vascular surgery determined? 
Physical fitness for surgery can be difficult to quantify.
Cardiopulmonary exercise testing (fig 1) is a validated technique
used to measure exercise capacity while monitoring cardiac and
respiratory function in response to a physical challenge. Outputs
from cardiopulmonary exercise testing include peak oxygen
uptake (VO  peak) and anaerobic threshold (VO  AT). These
have been sh
2	
own to correlate with length of hosp
2
ital stay,
pneumonia, myocardial infarction, and mortality after repair of
abdominal aortic aneurysm in several small studies.14-17 Patients 
with a lower anaerobic threshold may be declined surgery if the
risk is deemed to outweigh the benefit. Coexisting frailty,
symptomatic ischaemic heart disease, and reduced activity levels
due to fear of exercising with an aneurysm or limb pain due to
ischaemia tend to negatively affect the result of cardiopulmonary
exercise testing. 
What preoperative interventions can help
improve outcomes of vascular surgery? 
Optimisation for surgery can be broadly divided into improving
physical fitness, modifying lifestyle factors, and managing
coexisting medical conditions. There are no specific timelines;
however, the earlier these measures are discussed with the 
patient and initiated before surgery the better. 
Improving physical fitness 
Reassure patients that vascular conditions, especially abdominal
aortic aneurysm, are not a contraindication to low impact
physical activity. In a small trial (124 patients), a supervised
exercise programme for six weeks before surgery was associated
with fewer postoperative complications and length of hospital
stay following elective abdominal aortic aneurysm repair,
although short term mortality was unaffected.18 Preoperative
high intensity interval training involving short bursts of vigorous
exercise interspersed with periods of low intensity recovery was
found to be acceptable in patients with a large abdominal aortic
aneurysm in a small trial (27 patients).19 A systematic review
of exercise before abdominal aortic aneurysm repair found good
patient compliance (70-94%) in five studies (120 patients), using
programmes lasting between two and 12 weeks, and marked
improvements in anaerobic threshold.20 
Refer patients to specific information resources (box 1) on how
to maintain fitness with their condition. For patients with critical
limb ischaemia and limited ability to mobilise and exercise,
guidelines from the National Institute for Health and Care
Excellence (NICE) for management of rest pain recommend
referral to a specialist pain service.21 This may be suitable in
patients who have been turned down for revascularisation for
any reason, who need high doses of opioid analgesia, or in whom
pain persists even after surgery (including amputation). 
Box 1: Information resources for patients 
•	 The Vascular Society for Great Britain and Ireland provides free patient
information on all major vascular conditions, including advice on lifestyle
changes and moderate exercise: https://www.vascularsociety.org.uk/ 
•	 The Pre-Op Optimisation Project is a free resource developed by a
general practitioner. It covers a wide range of advice on how to reduce
preoperative risk before surgery, with links to guidelines and information
for doctors and patients alike: http://www.preop.org.uk/ 
•	 The Royal College of Surgeons of England has dedicated a section of
its website to patients who are going to have surgery, with answers to
common questions and clear advice when preparing for an operation:
https://www.rcseng.ac.uk/patient-care/having-surgery/things-to-consider­
before-having-surgery/ 
Optimising medical management 
Antiplatelet therapy 
Guidelines from NICE and European vascular
taskforces22 23recommend starting clopidogrel for suspected or
known carotid and peripheral disease at the time of referral to
vascular surgery. Aspirin is preferred in patients diagnosed with
abdominal aortic aneurysm although updated guidelines are
awaited. 
Antiplatelet therapy with aspirin or another agent is protective
in patients at risk of occlusive vascular events, such as
myocardial infarction, stroke, angina, cerebral ischaemia, or
peripheral arterial disease. A meta-analysis (287 randomised
controlled trials, 135 000 patients) identified a 34% proportional
reduction in myocardial infarction and a 26% reduction in
cardiovascular related event or death for patients with ischaemic
heart disease, peripheral arterial disease, or diabetes taking an
antiplatelet versus controls.24 Preoperative use of antiplatelets
and statins was associated with improved 30 day mortality (odds
ratio 0.76; 95% confidence interval 0.5 to 1.05; P=0.09) after
major vascular surgery in a large retrospective study (14 489
patients). Continuing these medications at discharge improved
five year survival (hazard ratio 0.5; 95% confidence interval
0.4 to 0.7; P<0.01).25 The CAPRIE trial (19 185 patients with
previous stroke, ischaemic heart disease, or peripheral arterial
disease) noted a relative reduction of 8.7% (confidence interval
0.3 to 16.5%; P=0.04) in annual risk of ischaemic stroke,
myocardial infarction, or vascular death with reduced
gastrointestinal bleeding events in patients treated with
clopidogrel (5.32%) compared with aspirin (5.83%).26 
Managing lipid levels 
Prescribing a short course of a statin about a month before
surgery has been associated with reduced cardiovascular events
and deaths compared with placebo in patients undergoing aortic,
carotid, and lower limb revascularisation surgery in two small
randomised controlled trials.27 28 NICE guidelines recommend
atorvastatin for patients with any cardiovascular disease (ie,
peripheral arterial disease, stroke, and abdominal aortic
aneurysm).29 They also recommend baseline tests for total low
density lipoprotein and high density lipoprotein cholesterol in
all patients diagnosed with these conditions. If available, the
results should be included in the referral letter to the vascular 
surgeon to prevent them being repeated. Test again three months
after commencing treatment. An increase in dose may be
required in patients already on a statin in whom recommended
targets have not been met. For example, guidelines from the
European Vascular Society recommend achieving a serum low
density lipoprotein cholesterol of <1.8 mml/L or a decrease of
≥50% of between 1.8 and 3.5 mmol/L for any patient with
peripheral arterial disease.22 
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Blood pressure control 
Hypertension is often diagnosed at the same time as an acute
vascular event, such as stroke, abdominal aortic aneurysm, or
acute limb ischaemia. A subgroup analysis (567 men aged
50-79) of the American Aneurysm Detection and Management
(ADAM) study found that abdominal aortic aneurysm growth
increased by up to 0.02 cm per year for every 10 mm Hg
increase in diastolic pressure (95% confidence interval 0.01 to
0.04; P=0.01).30 
Refer to NICE guidelines (CG127) on hypertension for blood
pressure control targets based on the stage of hypertension, age,
ethnicity, and comorbidities, such as diabetes, renal failure, and
signs of end organ damage. Initiate treatment at the time of
referral if indicated. The 2013 Cochrane review on blood 
pressure management in peripheral arterial disease (eight
randomised controlled trials, 3610 patients) failed to show
superiority of one antihypertensive agent over another in this
population due to study heterogeneity. Furthermore, it did not
find clear evidence that β-blockade should be avoided in the 
presence of peripheral arterial disease.31 Discuss with the patient
lifestyle interventions, such as smoking cessation, reducing
alcohol intake, weight loss, low salt intake (6 g/1 teaspoon a
day), and regular exercise, which will help with blood pressure
control and improve fitness for surgery.7 32 
Lung disease 
Severe lung disease, such as chronic obstructive pulmonary
disease (COPD), is associated with greater in-hospital mortality,
respiratory complications, and slower recovery after abdominal
aortic aneurysm repair, as seen in two large cohort studies in
the USA and Taiwan.33 34 
NICE guidelines35present clear stepwise guidance on the
diagnosis and management of COPD in primary care, including
when to refer a patient for specialist advice. The vascular team
can also refer the patient if there has been insufficient time to
manage the patient in primary care. If COPD has been diagnosed
in primary care, it is appropriate to initiate smoking cessation
and inhaled and oral medication while waiting for a vascular
review. 
Anaemia 
Detecting anaemia at the time of referral can indicate
concomitant disease, and can enable early treatment to reduce
the need for perioperative transfusion. 
Anaemia in vascular patients is often complicated by associated
comorbidity and use of antiplatelets. Evidence suggests that
preoperative anaemia and need for perioperative transfusion are
risk factors for poorer postoperative outcomes. In a large US
registry study (2946 patients), about a quarter of patients
undergoing vascular surgery required transfusion. Transfusion
was associated with an increased risk of death (odds ratio 6.94,
95% confidence interval 3.22 to 14.92; P=<0.001), myocardial
infarction (odds ratio 7.96, 95% confidence interval 3.74 to
16.92), and postoperative pneumonia (odds ratio 7.43, 95%
confidence interval 3.25 to 16.96; P=<0.001).36 The US national 
quality improvement database (941 496 adults undergoing
non-cardiac general, vascular, and orthopaedic operations) found
that patients receiving intraoperative transfusion had higher
unadjusted morbidity and mortality, which increased in a dose
dependent manner.37 A meta-analysis (24 observational studies,
949 445 patients) showed that in non-cardiac surgery patients
(vascular, orthopaedic, spinal, and upper gastrointestinal
operations), preoperative anaemia was associated with increased
need for perioperative transfusion, acute kidney injury (odds 
ratio 3.75, 2.95 to 4.76; P<0.001), infection (odds ratio 1.93,
1.17 to 3.18; P=0.01), and mortality (odds ratio 2.87, 2.10 to
3.93; P<0.001).38 
Obtain a full blood count at the time of referral to the vascular 
team, and communicate the results when known. Commence 
treatment alongside referral to the vascular team using the local
pathway for managing anaemia.39 
What other lifestyle modifications to
consider? 
Smoking cessation 
Offer urgent referral to a smoking cessation service, even if
surgery is imminent. Recommended interventions include
behavioural support by a trained counsellor, nicotine
replacement therapy, and medications such as varenicline and
bupropion.40 41 Smoking cessation support is offered in hospital;
however, the earlier patients stop before surgery, the greater the
benefits. 
Current smoking was associated with a 0.05 cm annual increase
in aneurysm expansion rate in those under surveillance in the
ADAM study (95% confidence interval 0.25 to 0.28; P<0.001).30 
Broadly speaking, cardiovascular risk reduces by up to a third
within two to four years after stopping smoking, reducing to
that of a non-smoker within 15 years.42 A pooled meta-analysis
(six randomised trials, 448 patients) noted that smoking
cessation using various interventions as little as two weeks
before a range of major surgical procedures led to a 41% relative
risk reduction in postoperative complications, including
abdominal wound infection and breakdown (relative risk 0.76,
95% confidence interval 0.69 to 0.84; P<0.0001) compared with
those who continued to smoke.43 An observational study among
739 patients undergoing surgery for peripheral arterial disease
found that those who stopped smoking within the year had lower
all cause mortality (14% versus 31%; hazard ratio 0.40; 95%
confidence interval 0.18 to 0.90) and improved amputation free
survival at five years (81% versus 60%; hazard ratio 0.43, 95%
confidence interval 0.22 to 0.86).44 
Frailty 
Frailty describes reduction in physiological reserve and
negatively affects tolerance and recovery from surgery. Frail
people are at greater risk of postoperative complications and
mortality, as seen in a large retrospective study in 23 207
patients undergoing repair of abdominal aortic aneurysm.45 
Defining frailty is challenging, but it is now included in the list
of preoperative risk factors in the UK national vascular quality
improvement audit, owing to evidence for its impact on
postoperative recovery. 
Validated tools for preoperative frailty assessment can help
identify patients at high risk of complications with vascular 
surgery.46 47 In primary care, multimorbidity and frailty can be
screened for opportunistically in at risk adults at the time of
referral using a validated tool, such as the electronic frailty
index. A falls assessment in patients with peripheral arterial
disease, a cognitive assessment in those with carotid disease,
and a medication review are advisable. The medication review 
is particularly pertinent, as many patients referred to a vascular
surgeon will be started on an antiplatelet (and proton pump
inhibitor) and statin, and are at risk of polypharmacy. 
Referral is often the point at which a patient with known frailty
risk factors begins to think about what matters to them—that 
is, quality of life over invasive treatment. Early discussion with
the vascular surgeon can be useful to address risk factors and 
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help the patient and their family make informed decisions about
treatment and postoperative care.48 
Education into practice 
How would you discuss physical activity with patients being referred for
a vascular condition based on reading this article? 
How do you discuss the importance of smoking cessation with your
patients? Will that change after reading this article? 
For patients with a documented diagnosis of vascular disease at your
practice, how many have had a blood pressure reading in the last 12
months? How many have had a lipid measurement in the last 12 months? 
Questions for further research 
•	 How can multidisciplinary programmes facilitate preoperative
optimisation of patients to improve outcomes for abdominal aortic
aneurysm repair, bypass, and major amputation? 
•	 Are optimisation programmes best delivered in the community or in
hospital? 
• How feasible and acceptable are optimisation programmes to patients? 
•	 Is earlier implementation associated with increased or reduced cost
associated with reduced postoperative events? 
•	 What is the impact of psychological preparation (if any) on patients
undergoing major vascular surgery? 
Additional educational resources for healthcare professionals 
•	 The Royal College of Surgeons of Edinburgh has partnered with the
antismoking charity Action on Smoking and Health to support surgeons
in encouraging patients to quit smoking ahead of surgery and improve
outcomes: https://www.rcsed.ac.uk/news-public-affairs/reports-and­
campaigns/smoking-and-surgery 
•	 Perioperative exercise testing and training society (POETTS) provides
consensus guidelines and resources on exercise testing, and
opportunities for training courses: https://poetts.co.uk/home?newsid=8 
•	 The Preoperative Association provides a comprehensive list of
preoperative guidelines for interested clinicians: https://pre-op.org/
preoperative-guidelines 
•	 NICE has developed a resource on preoperative pathways for patients
undergoing major or complex surgery, linked to relevant guidelines and
resources: https://pathways.nice.org.uk/pathways/preoperative-tests#
content=view-node%3Anodes-major-or-complex-surgery 
•	 The British Geriatrics Society (BGS) has developed a programme called
Fit for Frailty to support recognition of the frail patient and develop
strategies for managing it. It recommends the Edmonton Frail Scale for
assessing patients in the elective surgical setting. The programme aims
to dispel the myths of frailty being an inevitable or static condition that
cannot be improved on: https://www.bgs.org.uk/sites/default/files/content/
resources/files/2018-05-23/fff_full.pdf 
How patients were involved in the creation of this article 
We consulted six patients who had undergone surgery for repair of abdominal
aortic aneurysm, coronary artery bypass grafting, and major limb amputation
for peripheral arterial disease at the Centre for Exercise and Health, Coventry,
during the writing of this article. Patients with abdominal aortic aneurysm repair
and coronary artery bypass grafting described feeling underprepared and
weak, and had restricted their activity before surgery because of fears around
causing abdominal aortic aneurysm rupture or a heart attack. Patients with
peripheral arterial disease felt they had little time to prepare before their
amputation, or were in too much pain to consider any physical exercise. 
Patients recognised that smoking cessation, blood pressure control, and “best 
medical therapy” were important but they did not understand why these
measures would make any difference in the short time between diagnosis and
surgery. All felt that any physical activity before surgery would have needed
to be supervised at least once for their own confidence. 
This article has been written with this in mind, and describes key evidence for
interventions by the general practitioner and patient at the moment of referral.
We have shared some patient centred resources which can be given to, and
used by, patients before seeing a vascular surgeon. 
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Fig 1 Cardiopulmonary exercise testing 
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